Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer - Martín, M; Barrios, C H; Torrecillas, L (San Antonio Breast Cancer Symposium, 2018)
Abstr. GS2-04